Ambry Genetics
Focus: Ambry Genetics is a public-stage genetic testing company specializing in diagnostic panels and polygenic risk scores for rare diseases and cancer predisposition. The company operates in the molecular diagnostics and precision medicine space, focusing on RNA and DNA sequencing technologies.
Profile data last refreshed 13h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Ambry Genetics
AI assessmentNot HiringNo open roles listed right now. Follow Ambry Genetics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
RT-PCR
RNA Virus InfectionsClinical Trials (1)
NCT04517682COVID-19 and SARS-CoV-2 Detection in Saliva
N/AHelp build intelligence for Ambry Genetics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.